CDEK
← All trials

NCT06580041

Phase 4Interventional

Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

View on ClinicalTrials.gov ↗

Timeline

Start date
Nov 12, 2024
Primary completion
Sep 1, 2029
Completion date
Sep 1, 2029
First posted
Aug 30, 2024
Last posted
Oct 22, 2024
Enrollment
150
Arms / groups
10 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.